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Abstracts / Osteoarthritis and Cartilage 21 (2013) S63–S312 S79of their surgery. Radiographic severity was assumed to be constant
between time points. All SF samples underwent identical processing,
storage and preparation. Samples were analysed 9 pro-inﬂammatory
cytokines (IL1b, TNFa, IL6, IL8, IL15, IL2, IL12, IL17 & GMCSF), 4 regula-
tory cytokines (IL1RA, IL4, IL10, IL2R), 7 chemokines (Eotaxin, IP10,
MCP1, MIG, MIP1a, MIP1b, RANTES) and TGFb1, -b2 & -b3. Within-
subject comparison of the OKS and VASpain between time-points was
made using repeat measure statistical tests. P<0.05 was considered
statistically signiﬁcant. The repeatability of matched SF measurements
between time points was assessed for each analyte using the coefﬁcient
of variation (CV), and intraclass correlation coefﬁcient for absolute
agreement (ICC). The acceptable threshold for the interval CV (iCV) was
set at 20%, which is the threshold for acceptable intra- and inter-assay
precision. An ICC between 0.70-0.80 was considered strong absolute
agreement and ICC>0.80was considered excellent absolute agreement.
Results: The median interval between SF measurements was 16.5 days
(IQR 11.25 - 25). There was no signiﬁcant within-subject difference in
OKS or VASpain between time-points. There were no signiﬁcant clinical
or radiographic differences between the Study and Reference groups.
Only 10 analytes were >LOQ in all patient samples to allow meaningful
analysis: 4 pro-inﬂammatory cytokines (IL6, IL8, IL12 & IL15); 3 che-
mokines (Eotaxin, MCP1 & IP10); and the 3 isoforms of TGF-b. The
median iCV was <15% for all analytes and was signiﬁcantly less than
20% for all analytes (p<0.05, one sample Wilcoxon signed rank test).
The ICC was >0.88 for all analytes but one (TGF-b2, ICC¼0.75). For
measurements <LOQ or <LOD, there were no signiﬁcant differences in
the proportion of measurements below each limit between time-points
for any analyte (McNemar's exact test).
Conclusions: There is strong to excellent agreement in SF measure-
ments taken w2 weeks apart in patients with end-stage knee OA. The
study strongly suggests that there is stability in the SF biological proﬁle
over short intervals during which there has been no change in clinical
and radiographic severity. However, one must be cautious in general-
ising the results to all possible SF markers. We therefore advocate the
assessment of short-term sampling stability as part of the validation for
any potential OA biomarker.Figure. Mean log uC2C and uCTX-II concentrations decline between 4 and 16 weeks
after anterior crucicate ligament reconstruction. There is no difference in the slopes of
the biomarkers (p ¼ 0.098).133
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Purpose: Knee osteoarthritis (OA) is prevalent following anterior
cruciate ligament reconstruction (ACLR). Urinary concentrations of CTX-
II (uCTX-II), a biomarker of degradation of telopeptides of type II
collagen in articular cartilage, have been shown to be elevated in people
with knee OA. Our previous work has shown that uCTX-II concentra-
tions are also elevated from 4 to 16 weeks after ACLR. Cleavage of type II
collagen triple helices by collagenases has been measured with another
biomarker of articular cartilage degradation (C2C) which is elevated in
the serum of patients with OA. However, little is known about urinary
C2C (uC2C) concentrations in patients with ACLR. A new assay has
recently been developed for quantifying uC2C. Therefore, the purpose of
this study was 1) to examine changes in uC2C concentrations in the
early period after ACLR, 2) compare concentrations to age and sex-
matched controls, and 3) compare changes over time in uC2C and uCTX-
II and their association.
Methods: Urine samples were obtained from 28 subjects with ACLR
(19.6  4.5 yrs) and 28 age and sex-matched controls (19.9 4.3 yrs).
Testing was performed at 4, 8, 12 and 16 wk post surgery in ACLR and
one time point in controls. Early morning, second void urine samples
were obtained and stored at -20oC until analysis. uC2C (IB-C2C-HUSA,
IBEX Technologies) and uCTX-II (Urine CartiLaps, IDS Nordic a/s)
concentrations were analyzed using commercially available enzyme-
linked inmunosorbant assays (ELISA). Both biomarker concentrations
were corrected for creatinine concentration, determined by ELISA
(Caymen Chemical). Concentrations for both biomarkers were log
transformed prior to statistical analysis. Group differences in uC2C
concentrations were examined with paired sample t-tests, and with
linear regression after adjusting for body mass index (BMI). Slopes for
uC2C and uCTX-II across time were determined in ACLR. Paired sample
t-tests examined the differences between the slopes, and PersonProduct Moment correlation determined the association between the
slopes.
Results: Mean (SD) uC2C concentrations in ACLR were 838.2 (876.1),
688.1 (788.1), 775.1 (806.1), and 754.4 (825.6) ng/mmol at 4, 8, 12 and
16 weeks respectively; and in controls was 763.9 (804.7) ng/mmol. Log
uC2C concentrations were signiﬁcantly elevated in ACLR compared to
controls at all testing points, except 8 weeks post-surgery (p ¼ 0.01,
0.071, 0.008, 0.019; respectively). Results were similar after correcting
for BMI (p¼0.007, 0.051, 0.016, 0.018, respectively). Mean slopes for
uC2C (-0.016) and uCTX-II (-0.033) were negative and not signiﬁcantly
different (p ¼ 0.098). There was a moderate correlation between uC2C
and uCTX-II slopes (r¼ 0.652, p<0.01: Figure).
Conclusions: These results demonstrate that uC2C concentrations are
elevated at 4 wks after ACLR, decrease to levels comparable with
controls at 8 wk post ACLR, and become elevated again at 12 wk. The
increase in uC2C concentrations at 12 wk post-surgery coincides with
the typical initiation of advanced rehabilitation. Both uC2C and uCTX-II
concentrations indicate that articular cartilage degradation is initially
elevated after ACLR and improves over time. However, subtle differ-
ences between biomarkers exist. uC2C changes more dramatically over
time suggesting that it may represent acute changes in the joint envi-
ronment better than uCTX-II.134
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Purpose: The early detection of osteoarthritis is very favourable in
planning of future treatment. As in subclinical stages, it is only the
cartilaginous component of the ailment that we have to care for. No
joint erosion is usually encountered at such primary stages. Tomeet this
goal, there are researches going on over several biomarkers and genetic
markers to detect the disease in sub clinical stages or even identify the
genetically predisposed cases. There are several biomarkers being
globally studied which include Cartilage Oligomeric Matrix Protein
ĂAbstracts / Osteoarthritis and Cartilage 21 (2013) S63–S312S80(COMP), Hyaluronic Acid (HA), CTX-II and many others. Because of ease
of use and low cost, COMP and HA are most widely used biomarkers in
clinical set up. The purpose of this study is to compare the sensitivity
and speciﬁcity of diagnostic potentials of COMP and HA in knee
osteoarthritis.
Method: This is a prospective randomized control trial. A total of ﬁve
hundred and three patients of knee pain were screened. Out of this
three hundred and sixty patients met our inclusion criteria. Thus these
360 cases were enrolled in the study. They were equally divided into
two groups by a random serial, generated by computer. In both the
groups, severity assessment was done according to WOMAC Score and
Kellgren Lawrence Radiological Grading System. 5ml whole venous
blood sample of the recruited cases in both groups were drawn in
syringe and collected in plain vial taking all aseptic precautions. The
samples were tested for serum levels of COMP or HA by ELISA.
Following this cases were managed according to the guidelines of
OARSI. Follow up was planned at every six weeks.
Results: In both the groups, the biomarkers selected show considerably
high values. In COMP group increase in values with increasing severity
is more consistent as compared to that in HA group. However in HA
group, the difference between the normal and disease values were far
more signiﬁcant than COMP group. The serum HA estimation found to
have higher sensitivity but lower speciﬁcity than serum COMP esti-
mation. Also the serum HA values were signiﬁcantly elevated in mild
cases, which suggests the better role of serum HA estimation in early
detection of knee osteoarthritis as compared to serum COMP. However
serum COMP levels remain high for longer duration in contrast to
elevated serum HA levels.
Conclusion: In present study we recommend the use of serum HA
estimation for early detection of knee osteoarthritis. However if the
sample has to be drawn at a remote location and the time gap betweenĂcollection and processing is more than three hours, is it better to test
serum COMP instead, as in such cases serum HA estimation might show
a false negative value.Ă
Ă
